1795.TW
1795.TW
TW0001795003
LOTUS PHARMACEUTICAL CO
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 20.509.474.000 18.584.227.000
10.4%
Cost of Revenue 8.602.805.000 7.660.151.000
12.3%
Gross Profit 11.906.669.000 10.924.076.000
9.0%
6.010.362.000 4.907.058.000
22.5%
Operating Income 5.896.307.000 6.017.018.000
2.0%
Pretax Income 5.718.175.000 6.359.578.000
10.1%
Net Income Common Stockholders 4.720.053.000 5.065.510.000
6.8%
-- --
--
-- --
--
ende